Local Anesthetic Automated Intermittent Administration vs. Continuous Infusion Via Femoral Nerve Block.
NCT ID: NCT03696095
Last Updated: 2019-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
70 participants
INTERVENTIONAL
2018-04-16
2018-12-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Selective Tibial Nerve Block vs Local Infiltration Analgesia After Prothetic Knee Surgery
NCT03698006
Continuous Femoral Nerve Blockade and Readiness to Discharge Following Total Knee Arthroplasty
NCT00803348
Continuous Local Anesthesia Versus Continuous Femoral Nerve Bloc After Total Knee Arthroplasty: Impact on Mean Discharge Aptitude Delay
NCT02006355
Regional Anesthesia for Knee Prothesis Surgery
NCT02451605
Catheter-based Peripheral Regional Anesthesia After Total Knee Arthroplasty
NCT03372265
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continous infusion ropivacaine
Continuous infusion via peri-neural femoral nerve catheter of Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode) at rate of 6ml/h + patient controlled bolus of 3ml ...
Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode)
continuous infusion 6ml/h
PIB ropivacaine
Programmed intermittent bolus of Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode) : 6ml each 60min + patient controlled bolus 3ml ...
Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode)
programmed intermittent bolus 5ml each one hour.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode)
programmed intermittent bolus 5ml each one hour.
Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode)
continuous infusion 6ml/h
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* BMI \> 40
* refusal of loco-regional technique.
* psychiatric disease.
* inability to understand/ use the Local anesthetic delivery pump.
* local anesthetic allergy,
* porphyry,
* uncontrolled epilepsy,
* severe cardiac arrhythmia.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
J P Lecoq
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
J P Lecoq
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annis Orfi
Role: PRINCIPAL_INVESTIGATOR
University of Liege
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Liege
Liège, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-000822-70
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.